• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Publications

Ständer Sonja, Ketz Miriam, Kossack Nils, Pignot Marc, Chavda Rajeev, Gabriel Sylvie, Disease Burden, Healthcare Resource Utilization & Treatment Pattern among Patients with Prurigo Nodularis compared to a Benchmark in Germany: A Real-World-Evidence Claims Data Study. 31st EADV Congress, Milan. 2022;
Vogelmeier Claus F., Diesing Joanna, Kossack Nils, Pignot Marc, Friedrich Felix W., COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany. International Journal of Chronic Obstructive Pulmonary Disease. 2021; 2407–2417.
Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Carnarius H., Gairy Kerry, Levy R., Economic Burden of Organ Damage in Systemic Lupus Erythematosus: Results From a German Claims Analysis. DGRh Kongress. 2021; 10.3205/21dgrh064.
Birkeland Kåre I., Bodegard Johan, Banerjee Amitava, Kim Dae Jung, Norhammar Anna, Eriksson Jan W., Thuresson Marcus, Okami Suguru, Ha Kyoung Hwa, Kossack Nils, Mamza Jil Billy, Zhang Ruiqi, Yajima Toshitaka, Komuro Issei, Kadowaki Takashi, Lower cardiorenal risk with sodium glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study. Diabetes Obes Metab.. 2021; 23:75–85. 10.1111/dom.14189.
Schultze Michael, Garal-Pantaler Elena, Pignot Marc, Carnarius H., Levy R., Gairy Kerry, The Burden of Organ Damage Among Patients With Systemic Lupus Erythematosus in Germany. International Congress on Systemic Lupus Erythematosus. LUPUS & CORA 2021. 2021;
Moehner Sabine, Becker Kerstin, Lange Jens A., von Stockum Sophia, Serrani Marco, Heinemann Klaas, Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study Journal of Endometriosis and Pelvic Pain Disorders. 2021; 10.1177/2284026521993688.
Barnett Clare, Bauerfeind Anja, von Stockum Sophia, Heinemann Klaas, Thromboembolic safety profile of low-dose estradiol (valerate) in combined hormonal preparations: Implications for the development of new hormonal endometriosis and uterine fibroid therapies Journal of Endometriosis and Pelvic Pain Disorders. 2021; 1 - 10. 10.1177/22840265211019546.
Reed Suzanne, Koro Carol, DiBello Julia, Becker Kerstin, Bauerfeind Anja, Franke Christian, Heinemann Klaas, Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism European Journal of Contraception & Reproductive Health Care. 2021; 1 - 8. 10.1080/13625187.2021.1987410 .
Schwarting Andreas, Friedel H., Garal-Pantaler Elena, Pignot Marc, Wang X., Nab H., Desta Barnabas, Hammond E. R., The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource Utilization. Rheumatol Ther.. 2021; 10.1007/s40744-021-00277-0.
Reed Suzanne, Koro Carol, DiBello Julia, Becker Kerstin, Bauerfeind Anja, Franke Christian, Heinemann Klaas, Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study European Journal of Contraception & Reproductive Health Care. 2021; 1-7. 10.1080/13625187.2021.1988923.
Becker Kerstin, Heinemann Klaas, Imthurn Bruno, Marions Lena, Moehner Sabine, Gerlinger Christoph, Serrani Marco, Faustmann Thomas, Real world data on symptomology and diagnostic approaches of 27,840 women living with endometriosis. Scientific Reports. 2021; 10.1038/s41598-021-99681-3.
Dinger Jürgen, COCs containing dienogest and 30 μg ethinylestradiol may carry a higher VTE risk compared to corresponding preparations with levonorgestrel: A meta-analysis of four large cohort studies. Frontiers in Women's Health. 2020; Vol. 5: 1-6. 10.15761/FWH.1000175.
Download PDF: Jürgen-2020_COCs-containing-dienogest-and-30-μg-ethinylestradiol.pdf
  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 20
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.